Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is Eli Lilly's once-weekly tirzepatide injection, administered via a pre-filled KwikPen into the skin of the abdomen, thigh, or upper arm. Each pen contains four doses. The biggest mistake people make is treating the technique as obvious — it isn't, and getting it right from the first injection matters for both safety and effectiveness. Mounjaro is a prescription-only medicine; a prescriber assesses suitability before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people assume that because Mounjaro is a pre-filled pen, the technique requires no thought. In reality, the most common issues (pain at the site, a missed dose, a pen that appears not to fire) almost all trace back to a handful of avoidable preparation errors. The KwikPen is well-designed, but it does ask something of the person using it.
Start by taking the pen from the fridge at least 30 minutes before you plan to inject. Cold solution is considerably more uncomfortable going in. While it warms up, wash your hands thoroughly. Check the expiry date on the pen and the solution through the window, it should be clear and colourless. If it looks cloudy, discoloured, or contains particles, do not use it; contact your prescriber. You can find detailed guidance on the physical form of the pen on the Mounjaro KwikPen page.
Attach a fresh needle by screwing it straight onto the pen tip until it sits snug. Needles should never be shared and must be changed with every injection, reusing a needle blunts the tip and increases the risk of skin changes over time. Once attached, prime the pen only if the Instructions for Use state it is required for that specific pen; follow the Patient Information Leaflet precisely. If you want a full walkthrough of every physical step, our guide on how to use the Mounjaro pen takes you through the process from cap removal to disposal.
Tirzepatide is injected subcutaneously into one of three sites: the abdomen (at least 5 cm from the navel), the front of the thigh, or the outer upper arm. All three are clinically appropriate. The choice often comes down to practicality, the abdomen and thigh are easiest to manage alone; the upper arm tends to need assistance.
Rotation is not a suggestion. Injecting into the same small area week after week leads to lipohypertrophy, thickened, lumpy tissue that absorbs the medicine erratically. Move around systematically: different quadrant of the abdomen, alternate thighs, and so on. Our guide to Mounjaro injection technique covers site maps in more detail.
Clean the chosen site with an alcohol swab and let it dry fully, injecting before the alcohol evaporates stings. Pinch up the skin gently, press the pen firmly against the surface, and press the button. Hold it in place for the full count recommended in the leaflet (typically around ten seconds) before removing, so the full dose is delivered. You may hear a click when the injection starts and sometimes a second one when it ends. The viewing window will show the plunger has moved. For a step-by-step explanation of the full process, our detailed page on how to use Mounjaro injections covers everything from site preparation through to aftercare.
Dispose of the used needle immediately in a sharps container, never into household bins. Replace the pen cap and return the pen to the fridge for the following week's dose.
Mounjaro is taken once weekly, and consistency of timing helps, same day each week, give or take a day if something comes up. Many people anchor it to something they already do without thinking: a Sunday evening wind-down, a Monday morning before the commute, a fixed mid-week evening. Keeping the pen in the fridge door next to everyday items means it's never forgotten and never accidentally frozen at the back.
If you miss an injection and it has been fewer than four days since your usual day, take it as soon as you remember and continue from that day forward. If more than four days have passed, skip the missed dose entirely and resume on your next scheduled day. Never take two doses to compensate. The NHS tirzepatide medicines page sets out the missed-dose guidance clearly, and your Patient Information Leaflet is the definitive reference. When in doubt, ask your prescriber rather than guessing.
Storage matters beyond just the fridge temperature. Avoid leaving the pen in direct sunlight or a hot car. Do not freeze it, a frozen pen cannot be used. If you are travelling, a small insulated pouch is sufficient for short periods, within the room-temperature window stated in the leaflet. For full storage specifics, the Mounjaro SmPC on the eMC is the authoritative source.
Gastrointestinal effects are the most common: nausea, loose stools, constipation, indigestion, burping, and occasionally vomiting. They tend to peak in the days after a new dose or a dose increase, then settle. Eating smaller portions, avoiding fatty or very rich food, and staying well hydrated all make a meaningful difference. Fatigue and mild headache are also reported, particularly early in treatment.
Injection-site reactions (redness, mild bruising, or a small lump) usually resolve on their own and are less likely if you rotate sites carefully and let the pen warm up before injecting.
Two situations warrant urgent medical attention. First, severe abdominal pain that radiates to the back, with or without vomiting, should not be waited out, it could indicate pancreatitis, a known but infrequent risk that the MHRA flagged specifically for GLP-1 medicines in January 2026. Second, signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing) require emergency care immediately. You can report any suspected side effects through the MHRA Yellow Card scheme.
Tirzepatide is a prescription-only medicine. Decisions about dose changes, what to do if side effects persist, and whether treatment is still right for you belong with your prescriber. For a broader overview of the treatment itself, the Mounjaro information page covers the full clinical picture. If you are weighing up the cost of private treatment, this page on Mounjaro pricing in the UK explains what an honest price includes. Ready to talk to a clinician? Speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.